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patients were more likely to have annual cholesterol test, smoking status assessed, 
eye and renal function screening than normal weight patients. However, the over-
weight and obese class I/II patients were less likely to achieve optimal HbA1c (7% 
or less) and BP (< 130/80 mmHg) than normal BMI patients. The AdjOR for achieving 
optimal HbA1c decreased from 0.88 (95%CI 0.86-0.91) for overweight to 0.77 (0.72-
0.83) for obese class II; and BP decreased from 0.74 (0.99-1.05) for overweight to 0.48 
(0.45-0.52) for obesity class II. More obese class II and III patients had optimal LDL-
cholesterol control compared to normal BMI patients, AdjOR 1.11 (1.03-1.19) and 
1.16 (1.04-1.29) respectively. ConClusions: Overweight and obese patients with 
diabetes were less likely to achieve the optimal HbA1c and BP control than normal 
BMI patients. Clinicians can identify the patients with higher BMI and poor risk 
factor control for more intense intervention to improve diabetes care and outcomes.
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objeCtives: Investigating and comparing the sources of prevalence data used in 
German drug reimbursement dossiers within the AMNOG-framework in order to 
explore causes for deviating prevalence estimates. Methods: All publicly avail-
able dossiers on diabetes mellitus type II were retrieved from the Federal Joint 
Committee’s homepage (http://www.g-ba.de). We investigated the epidemiological 
sources in the dossiers on their representativity (i. e., population-level epidemiologi-
cal data), actuality (year of data collection), method of data collection, data quality, 
and open access. Results: As of early June 2014, 13 dossiers were published on 
diabetes mellitus type II. Overall, 23 different sources for quantifying the preva-
lence were used, which can be grouped into 5 categories: clinical trials, registries, 
health insurances’ claims data, commercial data-providers, and a governmental 
data-provider. Data was mostly collected 5 or more years ago (except for the com-
mercial and governmental data-providers). Data was retrieved by means of physi-
cians’ statements; patient surveys with voluntary disclosure; diagnostic tests (such 
as the oral glucose tolerance test); national registries; secondary data from health 
insurances, and (raw) secondary data of pharmacy prescriptions with physician 
diagnoses. Besides differences in diagnostic criteria, reasons for deviation among 
sources include: the sample size and making adjustments to improve representativ-
ity for Germany; the chosen approach to analyze secondary data; differentiation of 
type II from type I diabetes mellitus, and (not) considering undiagnosed or untreated 
cases. While accessing the data of publications and of the commercial providers 
requires a payment, health insurance data is not freely available in Germany (yet). 
The governmental data-provider is accessible without restrictions and free of 
charge. ConClusions: The need for accurate population-level data and access to 
it is highlighted by the present case-study. Sources for prevalence data in diabetes 
mellitus type II were characterized by a variety of differences in the methods applied 
to derive (the) data, leading to deviating estimates.
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objeCtives: Published studies have shown that lifestyle intervention in adults 
with prediabetes can improve health outcomes and reduce or delay onset of type 
2 diabetes. Improved health translates to lower medical costs, reduced mortality, 
and higher levels of employment and productivity. This study examined patient 
characteristics that help predict future medical expenditures avoided and economic 
benefits to society associated with lifestyle intervention. Methods: A Markov-
based microsimulation model utilizing Monte Carlo simulation was constructed to 
simulate patient health and economic outcomes over ten years with and without 
a lifestyle intervention. The population examined was a nationally representative 
sample (n= 2,887) of US adults with prediabetes from the 2003-2010 National Health 
and Nutrition Examination Survey who meet the American Diabetes Association’s 
screening criteria for diabetes. Prediction equations for diabetes and sequelae, medi-
cal expenditures, economic outcomes, mortality, and quality of life came from the 
published trials and studies, such as the UK Prospective Diabetes Study. The analy-
sis simulated body weight and hemoglobin A1c benefits reported in the 10-year 
follow-up results from the lifestyle arm of the Diabetes Prevention Program and 
Outcomes Study (DPPOS). OLS regression was subsequently used to analyze the 
initial patient characteristics and their relation to subsequent outcomes. Results: 
Simulated outcomes suggest that age, sex, race, obese status, and HbA1c at time 
of intervention are strong predictors of successful economic outcomes (medical 
expenditures and societal benefit). Intervention impact on medical savings generally 
increased with age through age 65, while total economic benefits of the interven-
tion increase through age 60. Women had $4,200 in higher medical savings then 
men. Obese participants had $3,000 higher medical savings than non-obese par-
ticipants. ConClusions: The expected economic benefit of lifestyle intervention 
varies systematically by patient characteristics. Patients age 55-64 experienced the 
most medical savings, while patients age 45-54 experienced the largest societal 
economic impact.
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objeCtives: Tight glucose control in critically ill patients is difficult and labor 
intensive, resulting in poor efficacy of glycemic control and increased hypoglyce-
mia rate. The purpose of this study was to evaluate the safety and effectiveness 
of the automated target glucose control using computer-based insulin algo-
of underreporting of hypoglycaemia in clinical hospital settings in Poland caused 
by DRG- based financing standards. There is a need of reflecting real treatment cost 
in the level of reimbursement in this group of patients.
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objeCtives: Diabetes Mellitus affects approximately 60 million Europeans, with 
prevalence increasing. Diabetes is associated with a number of severe comorbidi-
ties, including visual impairment, lower extremity conditions/amputation, neu-
ropathy, renal disease and cardiovascular disease. Managing underlying disease 
can significantly improve disease outcomes, though adherence remains a challenge. 
With the major expansion of consumer technology-based health care solutions and 
European initiatives like the REACTION project, diabetic patients are more involved 
in care than ever before. Our study looks at patient centric drivers of adherence to 
technology based diabetes self-management in Europe. Methods: An in-depth 
analysis of current European initiatives implementing digital health management 
solutions was performed, as well as overall demographic and statistical research 
of the European diabetes population. Additionally, using dual data collection meth-
ods, involving telephone-based interviews and internet-based questionnaires, a 
total of 2,307 diabetes patients in the US were sampled. Questions focused on 
demographic, lifestyle, treatment, access to information, and socioeconomic sta-
tus. Data from US diabetic patient preferences related to digital health solutions 
and patient engagement strategies were reviewed in the context of diabetes self-
management solutions being deployed in Europe. Results: Socioeconomic disad-
vantage amongst European citizens has been shown to significantly contribute to 
development of diabetes and related complications. Among our study population, 
diabetics with a lower socioeconomic status and the elderly showed drastically 
lower rates of access to internet at home or at work (58.1% and 66.3%, respectively), 
as compared to those who were employed with an average income > $60,000 (92.2%). 
This same group preferred to get information from their health care providers ver-
sus the internet. ConClusions: While programs are being developed to impact 
diabetic treatment adherence via IT based diabetes self-management solutions, 
patient characteristics and preferences need to be understood to optimize impact. 
Additional research is required to understand the best methods to reach these 
at-risk populations.
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objeCtives: In Ukraine, 1.2 million people have diabetes mellitus (DM). 80 insu-
lins and 169 oral hypoglycemic preparations are registered. However, incomplete 
information on DM patients results in problems with providing their medicines. 
To develop a computer information retrieval system (CIS) for the registration of 
patients with DM and their pharmacotherapy (including financing sources) and 
to optimize the requirements for medicines; the CIS can be used to analyse the 
pharmaceutical care of patients with DM. Methods: This study includes designin 
a CIS, entering pharmacotherapy information of DM patients, and use of the CIS 
to analyze the quality of pharmaceutical care of DM patients. Results: The study 
was conducted at the Ternopil Region, Ukraine. The study was based in 2 hospitals, 
2 dispensaries, and 12 pharmacies and examined the public and private sectors. 
The CIS was developed for use at national level and contains information on 
individual pharmacotherapy (27 insulins, 46 oral hypoglycemic preparations) of 
2,186 patients (282 DM type I). The CIS consists of 4 blocks: “Patient” (935 men, 
1261 women; from them 12 child) “Pharmacotherapy” (371 - insulin therapy, 1727 - 
oral hypoglycemic agents) and “Financing sources” blocks contain information on 
the centralized and local budgets, funds on maintenance of people that suffered 
from the Chernobyl accident, humanitarian help, and self-financing. The 4th block 
contains information on interactions of medicines. The analyses of individuals’ 
pharmacotherapies has shown that the CIS is an effective tool and can support 
endocrinologists in monitoring consumption of medicines by each patient. The 
system also provides expert analyses of changes of schemes, doses of medicines, 
and financing sources for individual patients. ConClusions: The CIS provides 
the doctor with the ability to precisely define what medicines are necessary for 
the patient, define availability of medicines, and raise rationality and safety of 
use of antidiabetic medicines.
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objeCtives: The study aimed to examine the disparity of risk factor screening and 
clinical outcomes depending on bodyweight of patients with diabetes mellitus at 9 
National Healthcare Group (NHG) Polyclinics in Singapore. Methods: Data were 
extracted from NHG Diabetes Registry. Diabetes care bundle measures of 8 process 
indicators (biannual blood pressure (BP), bodyweight and HbA1c test measurement, 
annual serum cholesterol level, smoking, eye, foot and nephropathy assessment) 
and 3 intermediate outcome indicators (HbA1c ≤ 7%, BP < 130/80 mmHg and LDL-C 
< 2.6mmol/L) were measured. Rates of these indicators were compared by BMI 
according to WHO classification. Multivariate logistic regression for achieving the 
individual indicators was referenced to the normal BMI group. Results: In 2012, 
87,552 patients were enrolled for diabetes care at 9 NHG Polyclinics. Mean age was 
64.1± 11.6. 51.8% were female. 70.6% were Chinese. 40.4% were overweight and 20.8% 
were obese. After adjusting for age, gender and ethnicity, overweight and obese 
